Phase 3b and 4 Post Approval Studies
Generate Real-World Evidence and Long-Term Insights With a Platform Built for Post-Approval Research
Phase 3b and Phase 4 studies extend beyond regulatory approval to evaluate long-term safety, effectiveness, treatment adherence, quality of life, and real-world outcomes. As studies become larger, longer, and more decentralized, THREAD helps sponsors simplify execution with a single configurable platform that supports global post-approval research while improving participant engagement and data quality.
Built for Long-Term Post-Approval Research
Whether you're conducting a label expansion study, post-marketing commitment, registry, pragmatic trial, or real-world evidence (RWE) study, THREAD provides the flexibility to manage participants over months or years while minimizing operational burden.
Our configurable no-code platform helps teams: • Launch post-approval studies faster • Support long-term participant engagement and retention • Collect real-world, patient-centered outcomes • Simplify hybrid and decentralized study execution • Capture high-quality longitudinal data • Scale globally across sites, countries, and languages
Expert Consulting for Post-Approval Studies
Post-approval studies require thoughtful planning to maximize participant retention and generate meaningful long-term evidence. THREAD's consulting team partners with sponsors to optimize study design, participant engagement strategies, protocol execution, and platform configuration, helping reduce operational complexity while improving study performance.
Our experts provide guidance on patient-centered study design, clinical outcome assessments (COAs), real-world evidence collection, participant engagement, and workflow optimization. Combined with our configurable no-code platform, THREAD helps sponsors efficiently generate high-quality evidence that supports regulatory commitments, reimbursement decisions, product differentiation, and ongoing clinical development.
